Episurf Medical signs letter of intent to sell medtech business to Oligo Medic
Bitget2026/10/26 13:30- Episurf Medical signed a letter of intent with Canada's Oligo Medic for the potential sale of its medical technology business.
- The proposed sale supports a shift toward real estate, following a strategic review disclosed on October 26, 2026.
- Oligo Medic plans to integrate the business into its joint-preservation treatment platform, FOREVER IN MOTION.
- No sale has been completed; a transaction remains subject to a definitive agreement and required approvals.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.
Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.
On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

Updated: CoreWeave Raises Revenue Forecasts, AI Demand Unfazed by Growing Doubts
TransUnion EVP Venkat Achanta reports sale of $2.36 million in common shares